Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Seer ( (SEER) ) has provided an announcement.
On May 21, 2026, Seer, Inc. announced that its board of directors unanimously rejected a further revised unsolicited, non-binding acquisition proposal submitted on May 14, 2026, by the Radoff-JEC Group to buy all outstanding Class A shares for $2.40 in cash plus a contingent value right. After consulting independent financial and legal advisers, the board concluded the offer significantly undervalued the company, remained materially similar to an earlier bid it rejected in April 2026, and implied an equity value below Seer’s existing cash, cash equivalents and investments.
The rejection underscores Seer’s assertion that its long-term growth prospects and balance sheet strength justify a higher valuation, signaling resistance to pressure from the activist investor group ahead of its 2026 annual shareholders’ meeting. The company has filed a preliminary proxy statement for the meeting and is preparing to solicit support via a definitive proxy and BLUE proxy card, highlighting a looming proxy contest in which stockholders will weigh in on Seer’s strategic direction and governance.
The most recent analyst rating on (SEER) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Seer stock, see the SEER Stock Forecast page.
Spark’s Take on SEER Stock
According to Spark, TipRanks’ AI Analyst, SEER is a Neutral.
The score is held down primarily by weak financial performance (small/declining revenue, large losses, and ongoing cash burn) and bearish technical positioning (trading below major moving averages with weak momentum). The earnings call adds partial support via reaffirmed guidance, cost discipline, strong cash reserves and buybacks, but near-term revenue/margin pressures and negative free cash flow keep overall risk elevated.
To see Spark’s full report on SEER stock, click here.
More about Seer
Seer, Inc., listed on Nasdaq as SEER, operates in the proteomics industry, providing deep, unbiased proteomic insights for research use. Its Proteograph Product Suite combines engineered nanoparticles, automated instruments, consumables and analytical software to overcome limitations of traditional proteomic methods, serving life sciences researchers but not diagnostic applications.
Based in Redwood City, Calif., the company positions itself as a pioneer and trusted partner in high-throughput proteomics, emphasizing scale, speed, precision and reproducibility. Seer focuses on enabling advanced protein analysis that can support drug discovery, biomarker research and other complex biological investigations across academia and industry.
Average Trading Volume: 378,574
Technical Sentiment Signal: Strong Sell
Current Market Cap: $92.37M
For an in-depth examination of SEER stock, go to TipRanks’ Overview page.